A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Clinical trial NCT02221960 · COMPLETED
Trial details
- NCT number
- NCT02221960
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2017-07-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.